Maria Katsogiannou

Title: Maria Katsogiannou: Innovator in Cancer Treatment

Introduction

Maria Katsogiannou is a prominent inventor based in Marseilles, France. She has made significant contributions to the field of cancer research, particularly in developing innovative treatments for chemo- and hormone-resistant cancers. With a total of two patents to her name, her work is paving the way for new therapeutic approaches.

Latest Patents

Katsogiannou's latest patents focus on nucleic acids targeting Translationally-Controlled Tumor Protein (TCTP). These inventions are designed to reduce the amount of TCTP in cells, which is crucial for treating or preventing hormone-independent and chemo-resistant cancers, such as androgen-independent prostate cancer. Her research highlights the potential of TCTP antagonists in revolutionizing cancer treatment.

Career Highlights

Throughout her career, Maria has worked with esteemed institutions, including the Institut National de la Santé et de la Recherche Médicale and Université de la Méditerranée Aix-Marseille II. Her dedication to advancing medical research has established her as a key figure in her field.

Collaborations

Katsogiannou has collaborated with notable colleagues, including Palma Rocchi and Virginie Baylot. These partnerships have further enhanced her research and contributed to her success in the scientific community.

Conclusion

Maria Katsogiannou's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. Her contributions are vital in the ongoing fight against cancer, and her patents represent a significant step forward in therapeutic options.